Not long after the FDA wrapped its preliminary investigation of GLP-1 receptor agonists and suicidal thoughts or actions, the ...

"Ozempic Santa" Elon Musk revealed he's been using a type 2 diabetes medication to lose weight: "Technically, Mounjaro, but ...

As weight-loss drugs have exploded in popularity this past year, part of the craze has been members of the public wondering which celebrities are on Ozempic.

Several other lawsuits are pending – including a hearing in New Jersey with testimony from Bristol Myers Squibb, Novo Nordisk, Novartis, and Johnson & Johnson that is due to start later this ...

A rep for the pharmaceutical company Novo Nordisk, which makes Ozempic ... The Real Housewives of New Jersey star declared "I am not on Ozempic" during a July 2024 Watch What Happens Live ...

Alabama now provides partial GLP-1 coverage for obesity: Among the obesity-indicated GLP-1s, Medicaid in Alabama covers just ...

Right now, Novo stock is trading at a forward price-to-earnings (P/E) multiple of 22.5 -- its lowest level in well over a year. I think now is a terrific opportunity to scoop up shares of Novo on the ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE ... affect the pharmaceutical and biotech industries, with new appointees potentially disrupting the regulatory landscape.

Financial giants have made a conspicuous bullish move on Novo Nordisk. Our analysis of options history for Novo Nordisk NVO revealed 8 unusual trades. Delving into the details, we found 50% of ...

Loomis Sayles, an investment management company, released its “International Growth Fund” third quarter 2024 investor letter.

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

Novo Nordisk has agreed its second acquisition in the space of a month of a biotech in the obesity category, snapping up fellow Danish company Embark Biotech for €15 million (around $16 million ...